4.6 Editorial Material

New insights on the role of CD8+CD57+ T-cells in cancer

Journal

ONCOIMMUNOLOGY
Volume 1, Issue 6, Pages 954-956

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/onci.20307

Keywords

melanoma; tumor-infiltrating lymphocytes; CTL; CD8(+) effector-memory; CD57

Funding

  1. NCRR NIH HHS [UL1 RR024148, TL1 RR024147] Funding Source: Medline

Ask authors/readers for more resources

Incomplete differentiation of CD8(+) cytotoxic T-lymphocytes (CTLs) in the tumor microenvironment is associated with cancer progression. We describe a new type of tumor-infiltrating CD8(+)CD57(+) T cell in cancer with hybrid phenotypic and functional properties of both an early effector-memory cell and a terminally-differentiated effector cell. These cells behave as incompletely-differentiated CTLs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available